Poly(I:C)-Mediated tumor growth suppression in EGF-receptor overexpressing tumors using EGF-polyethylene glycol-linear polyethylenimine as carrier

Pharmaceutical Research

Volumn 28, Issue 4, 2011, Pages 731-741

  Schaffert, David ^a   Kiss, Melinda ^a   Rödl, Wolfgang ^a   Shir, Alexei ^b   Levitzki, Alexander ^b   Ogris, Manfred ^a   Wagner, Ernst ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

epidermal growth factor; polyplex; receptor mediated delivery; RNA delivery; tumor targeting

Indexed keywords

DOUBLE STRANDED RNA; EPIDERMAL GROWTH FACTOR RECEPTOR; MACROGOL; MELITTIN; POLYETHYLENEIMINE; POLYINOSINIC POLYCYTIDYLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER THERAPY; CELL KILLING; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG TARGETING; GENE OVEREXPRESSION; GLIOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL SURVIVAL; DRUG CARRIERS; EPIDERMAL GROWTH FACTOR; GLIOBLASTOMA; HUMANS; MICE; MICE, NUDE; POLY I-C; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; RECEPTOR, EPIDERMAL GROWTH FACTOR; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79955604155     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0225-4     Document Type: Article

References (53)

1. PL Felgner Y Barenholz JP Behr SH Cheng P Cullis L Huang, et al. 1997 Nomenclature for synthetic gene delivery systems Hum Gene Ther 8 511 512 9095402 10.1089/hum.1997.8.5-511 1:CAS:528:DyaK2sXitlCmuro%3D (Pubitemid 27202042)
2. R Duncan 2003 The dawning era of polymer therapeutics Nat Rev Drug Discov 2 347 360 12750738 10.1038/nrd1088 1:CAS:528:DC%2BD3sXjslamtb0%3D (Pubitemid 37361705)
3. SD Li L Huang 2006 Gene therapy progress and prospects: non-viral gene therapy by systemic delivery Gene Ther 13 1313 1319 16953249 10.1038/sj.gt.3302838 1:CAS:528:DC%2BD28XptVClsLg%3D (Pubitemid 44323687)
4. M Meyer E Wagner 2006 Recent developments in the application of plasmid DNA-based vectors and small interfering RNA therapeutics for cancer Hum Gene Ther 17 1062 1076 17032153 10.1089/hum.2006.17.1062 1:CAS:528:DC%2BD28Xht1Smt7rK (Pubitemid 44749709)
5. DW Pack AS Hoffman S Pun PS Stayton 2005 Design and development of polymers for gene delivery Nat Rev Drug Discov 4 581 593 16052241 10.1038/nrd1775 1:CAS:528:DC%2BD2MXmsFGjtbo%3D (Pubitemid 40975711)
6. D Schaffert E Wagner 2008 Gene therapy progress and prospects: synthetic polymer-based systems Gene Ther 15 1131 1138 18528432 10.1038/gt.2008.105 1:CAS:528:DC%2BD1cXptlyhsLY%3D
7. E Wagner 2008 The silent (r)evolution of polymeric nucleic acid therapeutics Pharm Res 25 2920 2923 18679773 10.1007/s11095-008-9689-x 1:CAS:528:DC%2BD1cXhsVeqsrjI
8. KT Love KP Mahon CG Levins KA Whitehead W Querbes JR Dorkin, et al. 2010 Lipid-like materials for low-dose, in vivo gene silencing Proc Natl Acad Sci USA 107 1864 1869 20080679 10.1073/pnas.0910603106 1:CAS:528:DC%2BC3cXhvFSnsr0%3D
9. A Shir M Ogris E Wagner A Levitzki 2006 EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice PLoS Med 3 e6 16318410 10.1371/journal.pmed.0030006 (Pubitemid 43200638)
10. T Blessing M Kursa R Holzhauser R Kircheis E Wagner 2001 Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery Bioconjug Chem 12 529 537 11459457 10.1021/bc0001488 1:CAS:528:DC%2BD3MXksFemu70%3D (Pubitemid 32696226)
11. MF Wolschek C Thallinger M Kursa V Rossler M Allen C Lichtenberger, et al. 2002 Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice Hepatology 36 1106 1114 12395320 10.1053/jhep.2002.36372 1:CAS:528:DC%2BD38XovFaksb4%3D (Pubitemid 35253426)
12. S Boeckle E Wagner M Ogris 2005 C- versus N-terminally linked melittin-polyethylenimine conjugates: the site of linkage strongly influences activity of DNA polyplexes J Gene Med 7 1335 1347 15945120 10.1002/jgm.783 1:CAS:528:DC%2BD2MXht1Wkt7nE (Pubitemid 41555439)
13. M Meyer A Philipp R Oskuee C Schmidt E Wagner 2008 Breathing life into polycations: functionalization with ph-responsive endosomolytic peptides and polyethylene glycol enables sirna delivery J Am Chem Soc 130 3272 3273 18288843 10.1021/ja710344v 1:CAS:528:DC%2BD1cXitFegtbw%3D (Pubitemid 351456015)
14. ME Bonnet P Erbacher AL Bolcato-Bellemin 2008 Systemic delivery of DNA or sirna mediated by linear polyethylenimine (l-PEI) does not induce an inflammatory response Pharm Res 25 2972 2982 18709489 10.1007/s11095-008-9693-1 1:CAS:528:DC%2BD1cXhsVeqs7zP
15. S Ferrari E Moro A Pettenazzo JP Behr F Zacchello M Scarpa 1997 Exgen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo Gene Ther 4 1100 1106 9415317 10.1038/sj.gt.3300503 1:CAS:528: DyaK2sXmsFaitLw%3D (Pubitemid 27469941)
16. L Wightman R Kircheis V Rossler S Carotta R Ruzicka M Kursa, et al. 2001 Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo J Gene Med 3 362 372 11529666 10.1002/jgm.187 1:STN:280:DC%2BD3Mvoslagsw%3D%3D (Pubitemid 33691776)
17. M Thomas JJ Lu Q Ge C Zhang J Chen AM Klibanov 2005 Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung Proc Natl Acad Sci USA 102 5679 5684 15824322 10.1073/pnas.0502067102 1:CAS:528:DC%2BD2MXjslakt74%3D (Pubitemid 40559619)
18. J Carlsson H Drevin R Axen 1978 Protein thiolation and reversible protein-protein conjugation. N-succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent 90 Biochem J 173 723 737 708370 1:CAS:528: DyaE1MXhvVWktb0%3D (Pubitemid 9010965)
19. B Brissault A Kichler C Leborgne O Danos H Cheradame J Gau, et al. 2006 Synthesis, characterization, and gene transfer application of poly(ethylene glycol-b-ethylenimine) with high molar mass polyamine block Biomacromolecules 7 2863 2870 17025363 10.1021/bm060499a 1:CAS:528:DC%2BD28Xptleluro%3D (Pubitemid 44615271)
20. F Ungaro G De Rosa A Miro F Quaglia 2003 Spectrophotometric determination of polyethylenimine in the presence of an oligonucleotide for the characterization of controlled release formulations J Pharm Biomed Anal 31 143 149 12560058 10.1016/S0731-7085(02)00571-X 1:CAS:528:DC%2BD3sXmsFWqtg%3D%3D (Pubitemid 36120628)
21. SL Snyder PZ Sobocinski 1975 An improved 2, 4, 6-trinitrobenzenesulfonic acid method for the determination of amines Anal Biochem 64 284 288 1137089 10.1016/0003-2697(75)90431-5 1:CAS:528:DyaE2MXhsFWlsbc%3D
22. J Kloeckner S Bruzzano M Ogris E Wagner 2006 Gene carriers based on hexanediol diacrylate linked oligoethylenimine: effect of chemical structure of polymer on biological properties Bioconjug Chem 17 1339 1345 16984145 10.1021/bc060133v 1:CAS:528:DC%2BD28XptFait74%3D (Pubitemid 44455343)
23. K Hirabayashi J Yano T Inoue T Yamaguchi K Tanigawara GE Smyth, et al. 1999 Inhibition of cancer cell growth by polyinosinic-polycytidylic acid/cationic liposome complex: a new biological activity Cancer Res 59 4325 4333 10485480 1:CAS:528:DyaK1MXlvVSms7c%3D (Pubitemid 29418751)
24. AK Field AA Tytell GP Lampson MR Hilleman 1967 Inducers of interferon and host resistance. Ii. Multistranded synthetic polynucleotide complexes Proc Natl Acad Sci USA 58 1004 1010 5233831 10.1073/pnas.58.3.1004 1:CAS:528: DyaF2sXltFGltLs%3D
25. K Itaka A Harada Y Yamasaki K Nakamura H Kawaguchi K Kataoka 2004 In situ single cell observation by fluorescence resonance energy transfer reveals fast intra-cytoplasmic delivery and easy release of plasmid DNA complexed with linear polyethylenimine J Gene Med 6 76 84 14716679 10.1002/jgm.470 1:CAS:528:DC%2BD2cXhvVGgtrY%3D (Pubitemid 40228005)
26. P Erbacher T Bettinger P Belguise-Valladier S Zou JL Coll JP Behr, et al. 1999 Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI) J Gene Med 1 210 222 10738569 10.1002/(SICI)1521-2254(199905/06)1:3<210::AID-JGM30>3.0.CO;2-U 1:STN:280:DC%2BD3c3gtlSmtA%3D%3D (Pubitemid 129631076)
27. R Kircheis S Schuller S Brunner M Ogris KH Heider W Zauner, et al. 1999 Polycation-based DNA complexes for tumor-targeted gene delivery in vivo J Gene Med 1 111 120 10738575 10.1002/(SICI)1521-2254(199903/04)1:2<111::AID- JGM22>3.0.CO;2-Y 1:CAS:528:DyaK1MXjvVCmtLk%3D (Pubitemid 129631068)
28. M Kursa GF Walker V Roessler M Ogris W Roedl R Kircheis, et al. 2003 Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer Bioconjug Chem 14 222 231 12526712 10.1021/bc0256087 1:CAS:528:DC%2BD38Xpt1aju7g%3D (Pubitemid 36169036)
29. T Merdan K Kunath H Petersen U Bakowsky KH Voigt J Kopecek, et al. 2005 Pegylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice Bioconjug Chem 16 785 792 16029019 10.1021/bc049743q 1:CAS:528:DC%2BD2MXltVCitbc%3D (Pubitemid 41026164)
30. GF Walker C Fella J Pelisek J Fahrmeir S Boeckle M Ogris, et al. 2005 Toward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo Mol Ther 11 418 425 15727938 10.1016/j.ymthe.2004.11.006 1:CAS:528:DC%2BD2MXhsVOju74%3D (Pubitemid 40277318)
31. RS Burke SH Pun 2008 Extracellular barriers to in vivo PEI and pegylated PEI polyplex-mediated gene delivery to the liver Bioconjug Chem 19 693 704 18293906 10.1021/bc700388u 1:CAS:528:DC%2BD1cXitlOmsL4%3D (Pubitemid 351431402)
32. A Malek F Czubayko A Aigner 2008 PEG grafting of polyethylenimine (PEI) exerts different effects on DNA transfection and sirna-induced gene targeting efficacy J Drug Target 16 124 139 18274933 10.1080/10611860701849058 1:CAS:528:DC%2BD1cXhvVenurY%3D (Pubitemid 351266549)
33. AM Krieg AK Yi S Matson TJ Waldschmidt GA Bishop R Teasdale, et al. 1995 CpG motifs in bacterial DNA trigger direct B-cell activation Nature 374 546 549 7700380 10.1038/374546a0 1:CAS:528:DyaK2MXkvVKqtr8%3D
34. J Vollmer AM Krieg 2009 Immunotherapeutic applications of CpG oligodeoxynucleotide tlr9 agonists Adv Drug Deliv Rev 61 195 204 19211030 10.1016/j.addr.2008.12.008 1:CAS:528:DC%2BD1MXjtFKltb4%3D
35. H Poeck R Besch C Maihoefer M Renn D Tormo S Morskaya, et al. 2008 5′-triphosphate-siRNA: turning gene silencing and Rig-i activation against melanoma Nat Med 14 1256 1263 18978796 10.1038/nm.1887 1:CAS:528: DC%2BD1cXhtlCjtLzF
36. Besch R, Poeck H, Hohenauer T, Senft D, Häcker G, Berking C, Hornung V, Endres S, Ruzicka T, Rothenfusser S, Hartmann G. Proapoptotic signaling induced by rig-i and mda-5 results in type I interferon-independent apoptosis in human melanoma cells. J Clin Invest. 2009.
37. M Matsumoto T Seya 2008 TLR3: interferon induction by double-stranded rna including poly(i:C) Adv Drug Deliv Rev 60 805 812 18262679 10.1016/j.addr.2007. 11.005 1:CAS:528:DC%2BD1cXksVagsL8%3D
38. H Okada 2009 Brain tumor immunotherapy with type-1 polarizing strategies Ann NY Acad Sci 1174 18 23 19769732 10.1111/j.1749-6632.2009.04932.x 1:CAS:528:DC%2BD1MXhtlehs7rL
39. N Butowski KR Lamborn BL Lee MD Prados T Cloughesy LM DeAngelis, et al. 2009 A north american brain tumor consortium phase ii study of poly-iclc for adult patients with recurrent anaplastic gliomas J Neurooncol 91 183 189 18850068 10.1007/s11060-008-9705-3 1:CAS:528:DC%2BD1MXjvFehsQ%3D%3D
40. B Jasani H Navabi M Adams 2009 Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer Vaccine 27 3401 3404 19200817 10.1016/j.vaccine.2009.01.071 1:CAS:528:DC%2BD1MXmtlKgu7Y%3D
41. PG Milhaud P Machy B Lebleu L Leserman 1989 Antibody targeted liposomes containing poly(rI). Poly(rC) exert a specific antiviral and toxic effect on cells primed with interferons alpha/beta or gamma Biochim Biophys Acta 987 15 20 2557080 10.1016/0005-2736(89)90449-5 1:CAS:528:DyaK3cXhsVGgurk%3D (Pubitemid 20008992)
42. PG Milhaud B Compagnon A Bienvenue JR Philippot 1992 Interferon production of l929 and hela cells enhanced by polyriboinosinic acid-polyribocytidylic acid pH-sensitive liposomes Bioconjug Chem 3 402 407 1384719 10.1021/bc00017a008 1:CAS:528:DyaK38XlsFOms78%3D
43. F Sakurai T Terada M Maruyama Y Watanabe F Yamashita Y Takakura, et al. 2003 Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-beta gene and poly I: Poly C in a murine lung metastasis model Cancer Gene Ther 10 661 668 12944985 10.1038/sj.cgt.7700617 1:CAS:528: DC%2BD3sXmslSisbk%3D (Pubitemid 37129454)
44. J Kloeckner S Boeckle D Persson W Roedl M Ogris K Berg, et al. 2006 DNA polyplexes based on degradable oligoethylenimine-derivatives: combination with EGF receptor targeting and endosomal release functions J Control Release 116 115 122 16959361 10.1016/j.jconrel.2006.07.002 1:CAS:528:DC%2BD28Xht12jtLzN (Pubitemid 44854278)
45. K de Bruin N Ruthardt K von Gersdorff R Bausinger E Wagner M Ogris, et al. 2007 Cellular dynamics of EGF receptor-targeted synthetic viruses Mol Ther 15 1297 1305 17457321 10.1038/sj.mt.6300176 (Pubitemid 46965326)
46. AA Kale VP Torchilin 2007 Enhanced transfection of tumor cells in vivo using "Smart" Ph-sensitive tat-modified pegylated liposomes J Drug Target 15 538 545 17671900 10.1080/10611860701498203 1:CAS:528: DC%2BD2sXosVSktLw%3D (Pubitemid 47209054)
47. H Hatakeyama H Akita K Kogure M Oishi Y Nagasaki Y Kihira, et al. 2007 Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid Gene Ther 14 68 77 16915290 10.1038/sj.gt.3302843 1:CAS:528:DC%2BD28XhtlaqsL%2FL (Pubitemid 44942867)
48. C Rudolph U Schillinger C Plank A Gessner P Nicklaus R Muller, et al. 2002 Nonviral gene delivery to the lung with copolymer-protected and transferrin-modified polyethylenimine Biochim Biophys Acta 1573 75 12383945 1:CAS:528:DC%2BD38Xns1ahu7Y%3D
49. M Meyer E Wagner 2006 pH-responsive shielding of non-viral gene vectors Expert Opin Drug Deliv 3 563 571 16948553 10.1517/17425247.3.5.563 1:CAS:528:DC%2BD28XovF2gu7s%3D (Pubitemid 44383485)
50. V Knorr L Allmendinger GF Walker FF Paintner E Wagner 2007 An acetal-based pegylation reagent for pH-sensitive shielding of DNA polyplexes Bioconjug Chem 18 1218 1225 17477500 10.1021/bc060327a 1:CAS:528: DC%2BD2sXkvVCltrk%3D (Pubitemid 47122645)
51. JA Wolff DB Rozema 2008 Breaking the bonds: non-viral vectors become chemically dynamic Mol Ther 16 8 15 17955026 10.1038/sj.mt.6300326 1:CAS:528:DC%2BD2sXhsVKku77L
52. Y Han CG Caday A Nanda WK Cavenee HJ Huang 1996 Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors Cancer Res 56 3859 3861 8752145 1:CAS:528:DyaK28XltlSnsLk%3D (Pubitemid 26284726)
53. L Milas Z Fan NH Andratschke KK Ang 2004 Epidermal growth factor receptor and tumour response to radiation: in vivo preclinical studies Int J Radiat Oncol Biol Phys 58 966 971 14967457 10.1016/j.ijrobp.2003.08.035 1:CAS:528:DC%2BD2cXhtVyhu7k%3D (Pubitemid 38221157)